1. Home
  2. KEQU vs IPHA Comparison

KEQU vs IPHA Comparison

Compare KEQU & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kewaunee Scientific Corporation

KEQU

Kewaunee Scientific Corporation

N/A

Current Price

$38.00

Market Cap

124.6M

Sector

Industrials

ML Signal

N/A

Logo Innate Pharma S.A. ADS

IPHA

Innate Pharma S.A. ADS

HOLD

Current Price

$1.75

Market Cap

174.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KEQU
IPHA
Founded
1906
1999
Country
United States
France
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
124.6M
174.2M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
KEQU
IPHA
Price
$38.00
$1.75
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$5.00
AVG Volume (30 Days)
7.3K
26.1K
Earning Date
12-10-2025
09-17-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
3.94
N/A
Revenue
$285,515,000.00
$14,839,695.00
Revenue This Year
N/A
$22.29
Revenue Next Year
N/A
$43.90
P/E Ratio
$9.65
N/A
Revenue Growth
43.02
N/A
52 Week Low
$30.33
$1.60
52 Week High
$71.33
$2.63

Technical Indicators

Market Signals
Indicator
KEQU
IPHA
Relative Strength Index (RSI) 41.99 36.12
Support Level $37.91 $1.64
Resistance Level $39.61 $1.81
Average True Range (ATR) 1.11 0.08
MACD 0.10 -0.01
Stochastic Oscillator 14.11 22.58

Price Performance

Historical Comparison
KEQU
IPHA

About KEQU Kewaunee Scientific Corporation

Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.

Share on Social Networks: